Evidence map›Paper›PMID 32625631›Full record

ArticleEFSA journal. European Food Safety Authority2017

Guidance on the assessment of the biological relevance of data in scientific assessments.

EFSA Scientific Committee, Anthony Hardy, Diane Benford, Thorhallur Halldorsson, Michael John Jeger, Helle Katrine Knutsen, Simon More, Hanspeter Naegeli, Hubert Noteborn, Colin Ockleford and 24 more

Abstract read
In one paragraph

Article in EFSA journal. European Food Safety Authority, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Safety Assessment ofFoods (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Pathway Analysis Interpretation in the Multi-Omic Era.Biotech (Basel (Switzerland)) · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Flavouring group evaluation 420 (FGE.420): Hesperetin dihydrochalcone.EFSA journal. European Food Safety Authority · 2024
    Article
  14. Article
  15. Review
  16. Article
  17. Scientific opinion on the tolerable upper intake level for vitamin E.EFSA journal. European Food Safety Authority · 2024
    Article
  18. Guidance on risk-benefit assessment of foods.EFSA journal. European Food Safety Authority · 2024
    Article
  19. Article
  20. Scientific opinion on the tolerable upper intake level for iron.EFSA journal. European Food Safety Authority · 2024
    Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

EFSA Scientific Committee
Anthony Hardy
Diane Benford
Thorhallur Halldorsson
Michael John Jeger
Helle Katrine Knutsen
Simon More
Hanspeter Naegeli
Hubert Noteborn
Colin Ockleford
Antonia Ricci
Guido Rychen
Josef R Schlatter
Vittorio Silano
Roland Solecki
Dominique Turck
Maged Younes
Jean-Louis Bresson
John Griffin
Susanne Hougaard Benekou
Henk van Loveren
Robert Luttik
Antoine Messean
André Penninks
Giuseppe Ru
Jan Arend Stegeman
Wopke van der Werf
Johannes Westendorf
Rudolf Antonius Woutersen
Fulvio Barizzone
Bernard Bottex
Anna Lanzoni
Nikolaos Georgiadis
Jan Alexander

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

EFSA requested its Scientific Committee to prepare a guidance document providing generic issues and criteria to consider biological relevance, particularly when deciding on whether an observed effect is of biological relevance, i.e. is adverse (or shows a beneficial health effect) or not. The guidance document provides a general framework for establishing the biological relevance of observations at various stages of the assessment. Biological relevance is considered at three main stages related to the process of dealing with evidence: Development of the assessment strategy. In this context, specification of agents, effects, subjects and conditions in relation to the assessment question(s): Collection and extraction of data; Appraisal and integration of the relevance of the agents, subjects, effects and conditions, i.e. reviewing dimensions of biological relevance for each data set. A decision tree is developed to assist in the collection, identification and appraisal of relevant data for a given specific assessment question to be answered.

Indexed as

adverse effectbeneficial effectbiological relevancenature of the effectscientific assessmentsize of the effect

Identifiers

PMID32625631
PMCPMC7010076

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.